Effect of Gender-Affirming Hormone Therapy on CVD Risk in Transgender Women
No Thumbnail Available
Authors
Delgadillo, Raquel
Sanders, Kimberly
Wallace, Sara
Issue Date
2023-03-24
Type
Other
Language
en_US
Keywords
Hormone Replacement Therapy (HRT) , Cardiovascular Disease Risk , Transgender Women
Alternative Title
Abstract
The goal of this clinical review is to analyze the most recent studies and address the extent of the cardiovascular (CV) risk associated with taking estrogen hormone replacement therapy (HRT) in transgender females. 20 papers were analyzed and included in this final review. It was hypothesized that transgender women on estrogen HRT are at an increased risk for cardiovascular disease (CVD) compared to transwomen who do not take HRT. For the transgender population undergoing gender-affirming hormone therapy, CVD is the main cause of death. Previous studies looking at CV risk and transgender persons taking HRT have conflicting results.
Description
UB Rise 2023
Physician Assistant Institute
College of Health Sciences
University of Bridgeport